Industry news

• Сost of healthcare in Russia will amount to 6% of GDP by 2020 - deputy PM

  28 June 2013 The Voice of Russia

  Deputy Prime Minister Olga Golodets expects that by 2020, the health expenditures in Russia will be 6% of the GDP.
   

• The pharmaceutical market in Russia - current status, trends and changes

  11 June 2013 Tomasz Domagała, CEbiotech.com

  During his speech at BioForum 2013 in Budapest, Artur Shigabutdinov, from the Russian company Nadim Cro, characterized the pharmaceutical sector in Russia. He stressed the important role of generic drugs in the development of the pharmaceutical sector in the country, listed the factors stimulating development of the sector, as well as those that slow it down and talked about the changes in Russian legislation that reflect on the performance of the sector.

• Government obliges corporations to buy Russian technologies

  10 June 2013 Venture News

  The government intends to make a list of innovative products and services which share in state companies’ purchases should be increased. The priority will be given to Russian suppliers. 
   

• How to invest in Russian technoparks

  10 June 2013 Daniil Zhelobanov, Russia Beyond the Headlines

  In the 2000s, the Russian government came to regard technoparks as a perfect means of fostering innovation in the country's economy. Technoparks began to spring up all over the country, thanks to numerous government programs and initiatives. Five years ago, a World Bank study confirmed that one of Russia’s provinces, the Republic of Tatarstan, had more technoparks per capita than the country which invented them — the United Kingdom.

• EU, Russia Sign New Agreement On Combating Illicit Drugs

  07 June 2013 RTT News

  The European Union and Russia have signed a new agreement that will strengthen cooperation between the two sides in preventing drug precursors from being trafficked for the manufacture of illegal drugs, it was announced Tuesday.

• HemaCore Company’s device wins international design award

  06 June 2013 Venture News

  Trombodynamics Analyser produced by RUSNANO’s project company HemaCore and used for the blood coagulation system diagnosis has won the Red Dot Award in the Product Design category. German company WILDDESIGN developed the instrument design by order of HemaCore Company.

• Recent developments in the Russian pharmaceutical industry

  06 June 2013 Debevoise & Plimpton LLP Andrew L. Bab, Kevin A. Rinker, Dmitriy A. Tartakovskiy and Anna V. Maximenko / Lexology

  During the first few months of 2013, the Russian government has proposed, and in some cases adopted, new legislation that introduces a number of significant changes to the regulation of (1) the procurement of pharmaceuticals1 by Russian state-owned clinics, the Ministry of Health and other Russian federal, regional and local governmental authorities and financed from the federal, regional or municipal budgets (“Government Procurement”) and (2) the advertisement of biologically active substances and pharmaceuticals in Russia.    

• Russia signals for stronger bilateral relation with India in healthcare sector

  06 June 2013 Suja Nair Shirodkar, PharmBiz

  Russia has sent strong signal to strengthen the bilateral ties between the two countries in the healthcare sector, by inviting the Indian pharma companies and hospitals to set up their base in Russia. This was informed by the top representatives of the Russian government, during a high level interactive meeting in Mumbai recently.

• Successful First Edition of CPhI Russia Highlights Growth in Domestic Manufacturing and International Partnering

  06 June 2013 AsiaNet

  CPhI Russia reflected growth in the Russian Pharma market at its debut next to IPhEB, the St Petersburg International Forum for Pharmacy, Medical  Equipment, Biotechnology and Radiology, and is the latest addition to UBM  Live's global pharmaceutical events portfolio. The event was held in St Petersburg on April 2013 and  brought together senior Russian pharma professionals and international  pharmaceutical suppliers and buyers.

   

• Russian and US scientists launch type 2 diabetes drug program

  31 May 2013 Marchmont Innovation News

  Russian and US researchers have launched a joint project aimed at developing an innovation drug candidate to fight type 2 diabetes, the website of Russia’s ChemRar biotech research company announced earlier this week.